Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.597
+0.025 (4.43%)
At close: Apr 28, 2026, 4:00 PM EDT
0.589
-0.008 (-1.27%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $23.64 million as of April 28, 2026. Its market cap has decreased by -60.07% in one year.
Market Cap
23.64M
Enterprise Value
-36.71M
1-Year Change
-60.07%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $23.64M, an increase of 154.17%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 22.60M | -13.41% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 25.11M |
| Barinthus Biotherapeutics | 24.92M |
| AEON Biopharma | 24.91M |
| OSR Holdings | 24.65M |
| CEL-SCI | 24.60M |
| Tempest Therapeutics | 24.24M |
| Marker Therapeutics | 23.68M |
| Curis | 23.27M |